发明名称 MODIFIED RELEASE DOSAGE FORMS
摘要 In one embodiment, a dosage form comprises: (a) at least one active ingredient; (b) a molded core which is solid at room temperature; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium. In another embodiment of this invention, a dosage form comprises: (a) at least one active ingredient; (b) a molded core comprising a plurality of particles; and (c) a shell which is in contact with at least a portion of the core, wherein the dosage form provides modified release of the active ingredient upon contacting of the dosage form with a liquid medium.
申请公布号 WO03026615(A2) 申请公布日期 2003.04.03
申请号 WO2002US31116 申请日期 2002.09.28
申请人 MCNEIL-PPC, INC.;LEE, DER-YANG;LI, SHUN-POR;PARIKH, NARENDRA;MCTEIGUE, DAN;SOWDEN, HARRY, S.;THOMAS, MARTIN;WYNN, DAVID 发明人 LEE, DER-YANG;LI, SHUN-POR;PARIKH, NARENDRA;MCTEIGUE, DAN;SOWDEN, HARRY, S.;THOMAS, MARTIN;WYNN, DAVID
分类号 A23G3/34;A23G1/00;A23G1/54;A23G3/00;A23G3/04;A23G3/36;A23G3/54;A23L1/00;A23L1/09;A23L1/30;A61J3/00;A61J3/06;A61J3/10;A61K9/00;A61K9/14;A61K9/20;A61K9/22;A61K9/24;A61K9/26;A61K9/28;A61K9/30;A61K9/32;A61K9/34;A61K9/36;A61K9/38;A61K9/48;A61K9/50;A61K31/136;A61K31/137;A61K31/277;A61K47/10;A61K47/14;A61K47/26;A61K47/30;A61K47/32;A61K47/34;A61K47/36;A61K47/38;A61K47/44;A61K47/46;A61P11/00;B30B11/08;B30B11/34;B30B15/30;G06F17/30 主分类号 A23G3/34
代理机构 代理人
主权项
地址